These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9076296)

  • 1. Implications of the diabetes control and complications trial for persons with non-insulin-dependent diabetes mellitus.
    Vinik AI; Richardson DW
    South Med J; 1997 Mar; 90(3):268-82. PubMed ID: 9076296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
    Eastman RC; Siebert CW; Harris M; Gorden P
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes control and complications.
    Crofford OB
    Annu Rev Med; 1995; 46():267-79. PubMed ID: 7598463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the Diabetes Control and Complications Trial. American Diabetes Association.
    Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and early detection of vascular complications of diabetes.
    Marshall SM; Flyvbjerg A
    BMJ; 2006 Sep; 333(7566):475-80. PubMed ID: 16946335
    [No Abstract]   [Full Text] [Related]  

  • 7. Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
    Lebovitz HE; Vinik AI
    Am J Med; 1991 Feb; 90(2A):80S-84S. PubMed ID: 1994725
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons from the Diabetes Control and Complications Trial.
    Santiago JV
    Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-dependent diabetes mellitus: pathophysiology.
    Gerich JE
    Mayo Clin Proc; 1986 Oct; 61(10):787-91. PubMed ID: 3528691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCCT: implications for diabetes care in the UK.
    Boulton AJ
    Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapy for insulin-dependent diabetes mellitus.
    Mintz DH
    Med Sect Proc; 1993; ():157-69. PubMed ID: 8078868
    [No Abstract]   [Full Text] [Related]  

  • 15. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.
    Eastman RC; Javitt JC; Herman WH; Dasbach EJ; Copley-Merriman C; Maier W; Dong F; Manninen D; Zbrozek AS; Kotsanos J; Garfield SA; Harris M
    Diabetes Care; 1997 May; 20(5):735-44. PubMed ID: 9135935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial.
    Estacio RO; Savage S; Nagel NJ; Schrier RW
    Control Clin Trials; 1996 Jun; 17(3):242-57. PubMed ID: 8877260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninsulin-dependent diabetes mellitus. The prevention of complications.
    Fore WW
    Med Clin North Am; 1995 Mar; 79(2):287-98. PubMed ID: 7877391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran.
    Molla GJ; Ismail-Beigi F; Larijani B; Khaloo P; Moosaie F; Alemi H; Mansournia MA; Ghadimi T; Ghaemi F; Nakhjavani M; Esteghamati A
    Can J Diabetes; 2020 Apr; 44(3):246-252. PubMed ID: 31494031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.
    Valensi P; Giroux C; Seeboth-Ghalayini B; Attali JR
    J Diabetes Complications; 1997; 11(1):27-34. PubMed ID: 9025010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.